Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhengdaguangming Eye Group, centered around its flagship Weifang Eye Hospital, is a leading ophthalmic medical group in China's Shandong Province. Founded in 1999, the group provides a comprehensive range of eye care services, including cataract surgery, refractive surgery, vitreoretinal treatment, and pediatric ophthalmology. It operates as a large-scale clinical, teaching, and research institution, often collaborating on clinical trials for ophthalmic drugs and devices. The group has expanded into a network of multiple eye hospitals and optical centers across the region, serving millions of patients. It is recognized as a Grade 3A specialized hospital, the highest tier in the Chinese medical classification system, and integrates advanced medical technology with academic research through partnerships with several medical universities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhengdaguangming Eye Group-Weifang Eye Hospital.